Danaher Corporation (DHR)
Overview
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Explore More Data
Key Information
Stock Snapshot (Updated: Nov 05 04:00 PM EST)
Capital Structure (Updated: Nov 05 04:00 PM EST)
Calendar Events (Upcoming Earnings & Revenue Forecasts)
| Earnings | |
| Earnings Date (Estimated) | 2026-01-28 |
| Earnings Call (Estimated) | 2025-10-21 |
| Avg EPS Estimate | 2.1384 |
| Low EPS Estimate | 2.1 |
| High EPS Estimate | 2.225 |
| Revenue | |
| Avg Revenue Forecast | 6,785,455,380 |
| Low Revenue Forecast | 6,758,000,000 |
| High Revenue Forecast | 6,872,000,000 |
DHR Liquidity Indicators Shows key metrics that reflect cash availability and short-term payment ability
| Field | Value | Description |
|---|---|---|
| Cash Holdings | $1,528,000,000 | Cash on hand, which directly shows a company's ability to meet short-term obligations. |
| Quick Ratio | 0.835 | The quick ratio, which excludes inventory, measures short-term solvency; a value above 1 is considered relatively safe. |
| Current Ratio | 1.519 | The current ratio, calculated as current assets divided by current liabilities; the higher the value, the better the liquidity. |
| Total Debt | $18,155,999,232 | Total liabilities, used together with cash and liquidity ratios to assess debt burden. |
DHR Profitability Indicators Shows key metrics that reflect overall earnings, margins, and core business profitability
| Field | Value | Description |
|---|---|---|
| EBITDA | $7,629,000,192 | EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), which measures the profitability of core operations. |
| Operating Cash Flow | $6,318,000,128 | Operating cash flow, which reflects a company's cash-generating ability. |
| Free Cash Flow | $4,013,874,944 | Free cash flow, after deducting capital expenditures, which can be used for dividends or reinvestment. |
| Gross Margin | 59.59% | Gross margin; a higher value indicates stronger product profitability. |
| Operating Margin | 20.75% | Operating margin; slightly negative, indicating high operating costs. |
| Profit Margin | 14.44% | Net profit margin, which reflects overall profitability. |
DHR Leverage & Financial Health Indicators Shows key metrics that reflect debt levels, liquidity, and overall financial stability
| Field | Value | Description |
|---|---|---|
| Debt/Equity Ratio | 35.54% | Low leverage level, indicating the company has low debt pressure. |
| Total Debt | $18,155,999,232 | Used together with cash and EBITDA to assess debt-paying ability. |
DHR Growth Indicators Shows key financial metrics that reflect profitability, cash flow, and business expansion
| Field | Value | Description |
|---|---|---|
| Revenue Growth (YoY) | 4.40% | Rapid revenue growth, indicating fast business expansion. |
| Earnings Growth (YoY) | 13.40% | Significant EPS growth, indicating rapid improvement in profitability. |
Financial Data for DHR (Key ratios, margins, and cash flow)
| Field | Value | Description |
|---|---|---|
| Current Price | $212.21 | Latest stock trading price |
| Price Target (High) | $310 | Analyst highest expected price |
| Price Target (Low) | $220 | Analyst lowest expected price |
| Price Target (Average) | $254.4 | Average target price across analysts |
| Price Target (Median) | $252.5 | Median of target prices |
| Average Rating Score | 1.39 | Average analyst rating (1=Strong Buy, 5=Sell) |
| Consensus Recommendation | strong_buy | Consensus rating |
| Analyst Coverage Count | 20 | Number of analysts providing estimates |
| Cash Holdings | $1,528,000,000 | Total cash held by the company |
| Cash per Share | $2.16 | Cash value per outstanding share |
| Total Debt | $18,155,999,232 | Company's total debt |
| Quick Ratio | 0.835 | Ability to cover short-term liabilities (excludes inventory) |
| Current Ratio | 1.519 | Overall short-term liquidity |
| Debt/Equity Ratio | 35.54% | Leverage ratio: Debt / Equity |
| EBITDA | $7,629,000,192 | Earnings before interest, taxes, depreciation & amortization |
| Total Revenue | $24,267,999,232 | Total company revenue |
| Revenue per Share | $33.869 | Total revenue divided by shares outstanding |
| Gross Profit | 59.59% | Revenue minus cost of goods sold |
| Return on Assets | 4.06% | Net income / Total assets |
| Return on Equity | 6.84% | Net income / Shareholder equity |
| Earnings Growth (YoY) | 13.40% | Year-over-year EPS growth |
| Revenue Growth (YoY) | 4.40% | Year-over-year revenue growth |
| Gross Margin | 59.59% | Gross profit / Total revenue |
| EBITDA Margin | 31.44% | EBITDA / Revenue |
| Operating Margin | 20.75% | Operating income / Revenue |
| Profit Margin | 14.44% | Net income / Revenue |
| Free Cash Flow | $4,013,874,944 | Cash left after capital expenditures |
| Operating Cash Flow | $6,318,000,128 | Cash from core business operations |
| Currency | USD | Reported in US dollars |
| Last Updated | 2025-11-05 | Data source from Yahoo |